RNS Releases | Sopheon

Director Shareholdings (September 1, 2021) - Sopheon

Written by Sopheon | September 1, 2021

PDMR SHAREHOLDINGS

The Company has been notified that Stuart Silcock, a non-executive director of the Company, has sold 74,328 ordinary shares of 20 pence each (“Shares”) in the capital of the Company at a price of £9.63 per Share, pursuant to investor demand following the Company’s recent results.

Mr Silcock has also sold 5,000 Shares held in his dealing account as bare trustee for his grandchildren into his Self-Invested Personal Pension (“SIPP”) and has sold 1,000 Shares from his SIPP to the Individual Savings Account (“ISA”) of his spouse, Christine Silcock. Mrs Silcock has in turn sold 1,450 shares held in her dealing account to her ISA.

Stuart Silcock’s total beneficial interest in Ordinary Shares, including those held by his spouse or held on trust for family members, is now 279,490 Ordinary Shares.

 

For further information contact:

Andy Michuda (Executive Chairman)
Arif Karimjee (CFO)
Sopheon plc + 44 (0) 1276 919 560
Carl Holmes / Edward Whiley (Corporate Finance)
Alice Lane (ECM)
finnCap + 44 (0) 20 7220 0500

About Sopheon
Sopheon (LSE: SPE) partners with customers to provide complete enterprise innovation management solutions including software, expertise, and best practices, that enable them to achieve exceptional long-term revenue growth and profitability. Sopheon’s Accolade solution provides unique, fully-integrated coverage for the entire innovation management and new product development lifecycle, including strategic innovation planning, roadmapping, idea and concept development, process and project management, portfolio management and resource planning. Sopheon’s solutions have been implemented by over 200 customers with over 60,000 users in over 50 countries. Sopheon is listed on AIM, operated by the London Stock Exchange.